Also published in ncbi.nlm.nih.gov:
Characterization of Transfusion-Derived Iron Deposition in Childhood Cancer Survivors.
x hide permanently

Excellent treatment outcomes in children younger than 18 months with stage 4 MYCN nonamplified neuroblastoma.

ncbi.nlm.nih.gov

Excellent treatment outcomes in children younger than 18 months with stage 4 MYCN nonamplified neuroblastoma.

Korean J Pediatr. 2018 Feb;61(2):53-58

Authors: Kim C, Choi YB, Lee JW, Yoo KH, Sung KW, Koo HH

Abstract Purpose: Although the prognosis is generally good in patients with intermediate-risk neuroblastoma, no consensus has been reached on the ideal treatment regimen.